American Heart Journal
Volume 141, Issue 6 , Pages 949-956, June 2001

Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women’s Atorvastatin Trial on Cholesterol (WATCH)☆☆☆

Ottawa, Ontario, Canada, and Montreal, Quebec, Canada

From the aUniversity of Ottawa Heart Institute, Ottawa, Ontario, Canada, bParke-Davis Canada, Toronto, Ontario, Canada, and the cClinical Research Institute of Montreal, Montreal, Quebec, Canada

Received 30 September 1999; accepted 16 May 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by a grant from Parke-Davis Canada and Pfizer Canada. R. M. and J. G. are scientific consultants for Parke-Davis Canada. C. A. and P. M. are employed by Parke-Davis Canada.

☆☆ Reprint requests: Ruth McPherson, MD, PhD, FRCPC, Room H441, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, Ontario, Canada K1Y 4W7. E-mail: rmcpherson@ottawaheart.ca

PII: S0002-8703(01)59436-3

doi:10.1067/mhj.2001.115588

American Heart Journal
Volume 141, Issue 6 , Pages 949-956, June 2001

Article Tools

* Image Usage & Resolution